De Quervain's thyroiditis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 61: | Line 61: | ||
===Secondary Prevention=== | ===Secondary Prevention=== | ||
Revision as of 14:53, 1 August 2017
|
De Quervain's thyroiditis Microchapters |
|
Differentiating De Quervain's thyroiditis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]
Synonyms and keywords: Subacute granulomatous thyroiditis; subacute thyroiditis
Overview
De Quervain's thyroiditis usually occurs in women between 30 and 50 years of age. It is a member of the group of thyroiditis conditions known as resolving thyroiditis.
Historical Perspective
It is named for Fritz de Quervain.[1] It should not be confused with DeQuervain's syndrome.
Classification
Pathophysiology
Causes
Some cases may be viral in origin, perhaps preceded by an upper respiratory tract infection. Some cases develop postpartum.
Differentiating De Quervain's thyroiditis from other Conditions
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Patients will experience a hyperthyroid period as the cellular lining of colloid spaces fails, allowing abundant colloid into the circulation, with neck pain and fever. Patients typically then become hypothyroid as the pituitary reduces TSH production and the inappropriately released colloid is depleted before resolving to euthyroid. The symptoms are those of hyperthyroidism and hypothyroidism. In addition, patients may suffer from painful dysphagia. There are multi-nucleated giant cells on histology.
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography or Ultrasound
Other Imaging Findings
Treatment
Medical Therapy
Treatment is NSAID.
Corticosteroids may be of help in refractory cases.